340B: The Past, The Present, The Future?

Please join us for a three-part webinar series.

The 340B Program has grown into one of the most significant and rapidly evolving issues facing pharmaceutical manufacturers. Join us for a three-part virtual briefing as Covington’s leading life sciences team examines the program's evolution, the challenges shaping today's landscape, and the key legal, regulatory, and policy developments that may influence its future.

Session One: 340B: The Past
Understand the origins of today’s 340B challenges. Explore the key legislative, regulatory, and market developments that transformed the 340B Program into the second biggest drug pricing program in the United States.
Monday, November 2, 2026 | 12 - 1 p.m. ET
Speakers:  Jennifer Plitsch, Kristie Gurley, Aubrey Stoddard, Guillaume Julian

Session Two: 340B: The Present
Navigate the issues shaping the 340B landscape today. Gain practical insights into the latest litigation development, state legislative activity, and enforcement trends affecting pharmaceutical manufacturers.
Tuesday, December 15, 2026 | 12 - 1 p.m. ET
Speakers:  Jennifer Plitsch, Kristie Gurley, TJ Garrigan, Aubrey Stoddard, Guillaume Julian

Session Three: 340B: The Future?
Prepare for what comes next. As policymakers, regulators, and courts continue to examine the program, discover the emerging risks, opportunities, and strategic considerations that could define the future of 340B for pharmaceutical manufacturers.
Thursday, January 21, 2027 | 1 - 2 p.m. ET
Speakers:  Jennifer Plitsch, Kristie Gurley, TJ Garrigan, Aubrey Stoddard, Guillaume Julian

CLE: This program is pending approval for 1.0 hour CLE credit per session in California and New York. We will provide a Uniform Certificate of Attendance should you wish to self-report in another jurisdiction.

Event Details

Webinar Series:

Session 1:
Monday, November 2, 2026
12 - 1 p.m. ET

Session 2: 
Tuesday, December 15, 2026
12 - 1 p.m. ET

Session 3: 
Thursday, January 21, 2027 
1 - 2 p.m. ET

By Invitation Only.

Log-in Details Provided upon registration.

This event is closed to the press and to professionals from other law firms.